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Cognitive impairment in first-episode mania:
a systematic review of the evidence in the acute
and remission phases of the illness
Rothanthi Daglas1,2*, Murat Yücel3, Sue Cotton1,2, Kelly Allott1,2, Sarah Hetrick1,2 and Michael Berk1,2,4,5,6
Abstract
There isevidence of cognitive impairment that persists in the remission phase of bipolar disorder;however, the extent of
the deficits that occur from the first onset of the disorder remainsunclear.This is the first systematic review on cognitive
functioning in the early stagesof bipolar I disorder.The aim of the study wasto identify the patternsand degree of
cognitive impairment that existsfrom first-episode mania. Three electronic databases(MEDLINE,PsycINFOand PubMed)
were systematically searched for studiespublished from January 1980 to June 2014.Eligible studieswere separated into
two groups:acute and remission.The Newcastle-Ottawaquality assessment scale wasutilised to measure the quality of the
included studies.A total of seven studies(three acute and four remission), including 230 first-episode maniaand 345
healthy control participants,were eligible for the review.The studies in the acute phase only examined aspectsof executive
functioning,with impairments identified in cognitive flexibility, though not in response inhibition and verbal fluency relative
to healthy controls.The most consistent finding during the remission phase wasa deficit in working memory,whereas in
the other domains, the findingswere equivocal. Non-verbal memory and verbal fluency were not impacted in remission
from first-episode mania. In conclusion, deficitsare present in some but not all areasof cognitive functioning during the
early stagesof bipolar I disorder. Further research iswarranted to understand the longitudinal trajectory of change from
first-episode mania.
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Introduction
The presence and impact of cognitive changes in bipolar
disorder has more recently been widely appreciated. In-
deed, the presence of cognitive dysfunction is particu-
larly noteworthy given the evidence that many people
with bipolar disorder start out cognitively intact or with
even superior cognitive functioning (MacCabe et al.
2010). There remains an ongoing debate on the timing,
pattern and significance of these changes, including
whether cognitive impairments in bipolar disorder are
state-dependent or trait markers of the illness.
There is substantial evidence of cognitive impairments
in people who are in remission from acute episodes of
bipolar disorder, supporting that euthymia may not be a
period of complete recovery (Clark et al. 2002; Quraishi
and Frangou 2002; Latalova et al. 2011; Malhi et al.
2007; Martinez-Aran et al. 2004; Lewandowski et al.
2011). More specifically, several meta-analyses compar-
ing euthymic patients to healthy control (HC) partici-
pants have confirmed significant differences of medium
to large effect in tasks involving processing/psycho-
motor speed, attention, sustained attention, verbal
learning and memory, visual memory and executive
functions such as: set shifting, response inhibition, ver-
bal fluency and working memory (Arts et al. 2008; Bora
et al. 2009; Mann-Wrobel et al. 2011; Bourne et al.
2013; Robinson et al. 2006; Torres et al. 2007).
These findings are in contrast to reports suggesting
that asymptomatic people who subsequently will de-
velop bipolar disorder may show minimal or no cogni-
tive deficits prior to illness onset (MacCabe et al. 2010).
Berk et al. (2007a) modified the staging model for
* Correspondence: rdaglas@unimelb.edu.au
1Orygen, The National Centre of Excellence in Youth Mental Health, 35
Poplar Road, Parkville, VIC3052, Australia
2Centre for Youth Mental Health, The University of Melbourne, 35 Poplar
Road, Parkville, VIC3052, Australia
Full list of author information is available at the end of the article
© 2015 Daglas et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly credited.
Daglas et al. International Journal of Bipolar Disorders  (2015) 3:9 
DOI 10.1186/s40345-015-0024-2
bipolar disorder, identifying an opportunity for early inter-
vention with the potential that early use of pharmacological
treatments such as lithium carbonate may have neuropro-
tective properties (Swann et al. 1999; Franchini et al. 1999).
However, the majority of research on cognition in bipolar
disorder has been conducted on the later stages, and whilst
cognitive impairments appear to worsen with illness pro-
gression (Robinson and Ferrier 2006), the extent and pat-
tern of cognitive dysfunction in the early stages remain
largely unknown.
First-episode mania (FEM) is a crucial time for the
trajectory of cognitive change. Hence, identifying cogni-
tive deficits that may be present prior to the effects of
multiple episodes and prolonged exposure to psycho-
tropic treatment is theoretically important, whilst also
informing approaches to early intervention (Berk et al.
2010). To date, there has only been one meta-analysis
on cognitive functioning in first-episode bipolar dis-
order, with the findings of deficits ranging from small to
large effect for processing speed, attention, verbal learn-
ing and memory and executive functions in patients
relative to HCs (Lee et al. 2014). However, this study in-
cluded all phases of bipolar disorder (i.e. depression,
hypomania, mania, mixed or psychosis) as a first epi-
sode, and the study was restricted to adult samples. The
mean age of onset of bipolar disorder typically is in ado-
lescence at about age 17 (Berk et al. 2007b). Perlis et al.
(2004) found in their sample of 1,000 participants with
bipolar disorder that approximately 40% had an early
age of onset between 13 and 18 years of age, which was
linked to a more severe course of illness and an in-
creased likelihood of comorbid disorders.
This review will be the first to include adolescents
with bipolar disorder and to provide a formal systematic
quality assessment of the studies on cognitive impair-
ment in FEM. The assessment of cognitive change from
FEM is crucial in better understanding whether cogni-
tive deficits are progressive or already present from the
first diagnostic episode of bipolar I disorder. The main
objective was to identify the degree and pattern of cog-
nitive deficits present in FEM by systematically review-
ing the literature focusing on two illness phases:
cognitive functioning during the first acute manic state
and in the following remission period.
Methods
Search strategy
A comprehensive search of the literature on cognitive
functioning in FEM was undertaken using three elec-
tronic databases, MEDLINE (Thompson Reuters Web
of Knowledge), PubMed (United States Library of Medi-
cine) and PsycINFO (Wolters Kluwer Health OvidSP).
The following terms were searched in the title and ab-
stract fields: ‘first episode mania’; ‘single manic episode’;
‘first episode bipolar disorder’; ‘early onset mania’or ‘early
onset bipolar disorder’along with ‘neurocognition’,‘neu-
rocognitive’,‘neuropsych*’,‘cognition’,‘cognitive’,‘execu-
tive function’, ‘attention’, ‘memory’, ‘processing speed’,
‘intelligence’, ‘intellectual’or ‘IQ’. The search was lim-
ited to English-language articles published between 1
January 1980 and 1 June 2014.
Inclusion and exclusion criteria
To be eligible for inclusion, the studies had to meet the
following criteria: (1) cross-sectional study design, (2) a
participant group of patients with FEM (or a first mixed
episode) satisfying criteria for a diagnosis of either bipo-
lar I disorder or schizoaffective disorder by the use of a
standardised diagnostic manual, (3) a comparison sam-
ple of age and sex group-matched HCs, (4) the adminis-
tration of objective and standardised cognitive tests, (5)
cognitive functioning comparisons between the psychi-
atric group and HCs, (6) studies with more than one
psychiatric group must have had made clear compari-
sons of the FEM patients (as a distinct group) and HCs
and (7) comparison groups must have included a sample
size of more than 15 participants. The exclusion criteria
for FEM participants were as follows: (1) a previous
medically treated manic episode and (2) a neurological
disorder including severe head trauma and/or a history
of epilepsy/seizures.
Study selection
Across all three databases, the search generated 217
journal articles that made reference to the search terms
in their titles and abstracts. Of the 217 articles identi-
fied, 134 remained after duplicates were removed. Full
texts of the remaining articles were retrieved and
assessed to determine whether they met the inclusion
and exclusion criteria for this review (see Figure 1). Ref-
erence lists of all eligible studies were checked for fur-
ther relevant studies resulting in the identification of
one extra article (Lopez-Jaramillo et al. 2010). The first
author (RD) screened and reviewed all articles for eligi-
bility, which were confirmed by the second author
(MY). Any uncertainties or discrepancies were discussed
and mutually resolved by meticulous observation of the
inclusion and exclusion criteria. Studies that compared
different cognitive domains, albeit of the same cohort,
were deemed eligible for the review (e.g. Fleck et al. 2008;
Lebowitz et al. 2001; Strakowski et al. 2008). However,
when the same cohort (or a percentage of the same partic-
ipants) was used across several studies that compared
similar cognitive domains, the primary study with cogni-
tion as the main variable was selected for inclusion in the
review to avoid repetition of results. This resulted in the ex-
clusion of secondary studies that compared the effects of
sex, traumatic events, neurosubstrates, social functioning or
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previous depressive episodes as variables related to cogni-
tive functioning (Bucker et al. 2013; Bucker et al. 2014;
Hellvin et al. 2013; Kozicky et al. 2013; Muralidharan et al.
2014).
Study participants
All eligible studies were separated into two groups: acute
and remission. Participants in the acute group represented
individuals experiencing an acute manic episode during the
Figure 1 Study selection process according to PRISMA guidelines (Moher et al. 2009).
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time of the cognitive assessment, whereas the participants in
the remission group were predominantly euthymic at the
time of testing.
Data extraction and analysis
A data extraction form was used to extract and record all
pertinent methodological information and sample character-
istics. All relevant statistical analyses from the studies (in-
cluding mean, standard deviations, statistical tests, p-values
and effect sizes) were compiled and recorded. A meta-
analysis was not performed due to the restricted number of
studies in the acute and remission groups and due to the
large variety in cognitive tests used across the studies.
A semi validated quality assessment tool recommended
by Cochrane for non-randomised studies was used to
measure the quality of the included studies (Higgins and
Green 2011). The Newcastle-Ottawa quality assessment
scale offers a comprehensive measurement for risk of bias
that can be applied to case-control and cohort study de-
signs (Wells et al. 2006). The scale incorporates a ‘star sys-
tem’in which each study can receive up to a maximum of
nine stars if all criteria have been satisfied within three cat-
egories: selection, comparability and exposure/outcome.
The tool has been rated as one of the better quality assess-
ment scales for use in systematic reviews of observational
studies (Deeks et al. 2003).
Results
Types of studies
In total, seven studies were considered eligible for this sys-
tematic review. Of these, three focussed on acute patients
who were inpatients for FEM at the time of the cognitive
testing. The four remaining studies examined participants
in the period following acute FEM, though some ongoing
symptomatology was present in one study.
Type of participants
The sample characteristics of the included studies are pre-
sented in Table 1. In total, the studies comprised 230 FEM
participants and 345 HCs. The sample sizes were generally
small, ranging from 16 to 50 for the FEM groups and from
16 to 110 for the HC groups. Across the studies, the aver-
age age of the HC group (from 20 to 37 years) was com-
parable to that of the FEM samples (from 19 to 37 years).
Overall, the FEM and HC groups had a close to equal pro-
portion of males and females (56%and 51%, respectively).
Types of cognitive tests
The neuropsychological batteries comprised cognitive
tests that were standardised to the general population,
psychometrically sound and widely used in this patient
population (Strauss et al. 2006; Mitrushina et al. 2005).
The Bergen n-back test was excluded from the review due
to weak construct validity (Kane et al. 2007; Jaeggi et al.
2010). The continuous visual execution task and semantic
memory with associative increment test were also not in-
cluded in the analysis due to the lack of information avail-
able on test description and normative data to verify that
the test was standardised as per inclusion criteria. The
tests used across the studies covered the following cogni-
tive domains: processing speed, attention, learning and
memory, visuospatial orientation, executive functioning
and intelligence. A list of all the cognitive tests represent-
ing the aforementioned domains is available as Additional
file 1: Table S1.
Methodological quality
The Newcastle-Ottawa criteria and total scores for each
study are presented in Table 2. Overall, the methodology
of the studies posed several potential biases, with at least
three quality indicators omitted from each study. The
mean scale score across the studies was 6 out of 9, with
two studies satisfying less than half of the quality assess-
ment markers. Details of potential methodological bias
are described below.
Selection Two studies did not provide the details of in-
dependent validation (such as use of participant’s clinical
records) to confirm the case definition (Elshahawi et al.
2011; Strakowski et al. 2008). Three of the seven studies
were not broadly representative of the clinical popula-
tion as they only included inpatients or patients with
psychotic features (Elshahawi et al. 2011; Lebowitz et al.
2001; Strakowski et al. 2008). Lebowitz et al. (2001)
omitted pertinent details of the hospital and the commu-
nity from which the patients and HCs had been re-
cruited and the period of recruitment; the definition of
HCs was also not sufficient. Based on the author affili-
ation details provided by Lebowitz et al. (2001), it ap-
pears that the FEM participants were recruited from the
same inpatient units as those from the other two acute
studies. Fleck et al. (2008) did not provide clear details
of the community from which the HC group were re-
cruited. Elshahawi et al. (2011) only recruited employees
from Ain Shams University Hospitals as their HC partic-
ipants, whilst Lopez-Jaramillo et al. (2010) recruited the
patients’relatives as their HC group.
Comparability The FEM and HC groups were well
matched on several demographic variables. In addition
to age and gender, the comparison groups were matched
on estimated premorbid intelligence quotient (IQ)
(Lebowitz et al. 2001; Torres et al. 2010; Fleck et al.
2008; Hellvin et al. 2012), education (Elshahawi et al.
2011; Hellvin et al. 2012; Lopez-Jaramillo et al. 2010;
Torres et al. 2010), ethnicity (Lebowitz et al. 2001;
Strakowski et al. 2008), religion (Elshahawi et al. 2011),
marital status (Elshahawi et al. 2011) and occupation
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Table 1 Sample characteristics of FEM patients and HCs of included studies
Group First author (year) Control participants FEM participants
Total Male Age
(years)
Education
(years)
Estimated IQ Total Male Age
(years)
Education
(years)
Estimated
IQ score
YMRS score Age of
onset
N n (%) Mean (SD) Mean (SD) Score (SD) N n (%) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Acute Fleck et al. (2008) 48 20 (41.6) 28.2 (7.9) 12.8 (1.4) 108.7 (9.0) 21 11 (52.4) 25.7 (9.2) 11.6 (2.2) 105.2 (10) 21.7 (11.8) NR
Lebowitz et al. (2001) 30 13 (43.3) 31.2 (8.1) 13.16 (1.1) 109.5 (8.8) 19 10 (52.6) 27.4 (7.17) 11.9 (2.0) 103.7 (8.5) 16.6 (9.1) 23.3 (6.9)
Strakowski et al. (2008) 16 9 (56) 20 (4) 13 (3) NR 16 12 (75) 19 (4) 11 (3) NR 25 (7) NR
Remission Elshahawi et al. (2011) 50 29 (58) NR NR NR 50 33 (66) 26.4 (4.7) NR NR NR NR
Hellvin et al. (2012) 110 49 (44.5) 31.1 (9.8) 13.4 (1.9) 111.6 (4.9) 34 15 (44.12) 31.2 (9.6) 13.1 (2.2) 110.9 (6.6) 2 (0 to 28)b 23 (11 to 53)b
21a 8 (38) 30.5 (10.6) 12.9 (2.3) 109.5 (5.1) 5 (0 to 19)b 17 (10 to 37)b
Lopez-Jaramillo et al. (2010) 66 44 (66.6) 37.44 (8.57) 9.61 (3.28) NR 24 16 (66.6) 37.04 (10.19) 10.92 (3.79) NR 1.21 (1.5) 25.79 (9.98)
Torres et al. (2010) 25 12 (48) 22.5 (4.8) 14.3 (2.4) 107.4 (7.7) 45 23 (51) 22.2 (3.9) 13.4 (2.4) 107.2 (7.1) 1.8 (3.7) 19.3 (4.4)
YMRS, Young Mania Rating Scale; NR, not reported. aFEM participants with previously untreated manic symptoms; bmedian (min-max).
Daglas
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Table 2 Methodological quality assessment for the FEM studies (Newcastle-Ottawa scale)
Group First author
(year)
Selection Comparable Exposure/outcome Total stars
(out of 9)
Validation of
case definition or
cohort exposure
Representative
sample
Selection of
controls or
non-exposed
cohort
Definition of
controls or
non-exposed
cohort
Groups comparable
in design
and analysis
Assessment
of exposure
or outcome
Same method
used for both
groups or adequate
follow-up period
Non-response
rate or loss
to follow-up
Acute Fleck et al.
(2008)
* * − * ** − − − 5
Lebowitz
et al. (2001)
* − − − ** − * − 4
Strakowski
et al. (2008)
− − * * ** − * * 6
Remission Elshahawi
et al. (2011)
− − − * ** − * − 4
Hellvin et al.
(2012)
* * * * ** − * − 7
Lopez-Jaramillo
et al. (2010)
* * − * ** − * − 6
Torres et al.
(2010)
− * * * ** − * − 6
*criteria was met; **criteria was met and awarded two stars (comparability only); −criteria was not met.
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(Elshahawi et al. 2011; Lopez-Jaramillo et al. 2010). One
study did not match groups in education (Lebowitz et al.
2001).
Exposure/outcome None of the seven studies satisfied
the criteria for the assessment of exposure/outcome, as
the interviewer was not blind to whether the participant
was a FEM patient or HC. Most studies used the same
method of ascertainment for both FEM and HC partici-
pants, but this was not clearly specified in one study
(Fleck et al. 2008). Furthermore, clear details regarding
missing data were not provided by most studies, besides
for one study (Strakowski et al. 2008).
Other On the surface, the approaches used for statistical
analyses seemed appropriate, and the conversion of raw
scores to z-scores further standardised individual scores
(Hellvin et al. 2012; Lebowitz et al. 2001; Torres et al.
2010; Lopez-Jaramillo et al. 2010). However, many of the
studies failed to adjust for the effects of potential con-
founding variables such as premorbid IQ or clinical vari-
ables and medication effects for the FEM group.
Confidence intervals and effect sizes were seldom re-
ported. The absence of hypotheses (Elshahawi et al.
2011; Hellvin et al. 2012), post hoc analyses (Elshahawi
et al. 2011) or the description of the type of post hoc
analysis used (Lebowitz et al. 2001) may also be viewed
as methodological weaknesses of some of the studies.
Moreover, four studies comprised small sample sizes
(under 30 participants) (Fleck et al. 2008; Lebowitz et al.
2001; Lopez-Jaramillo et al. 2010; Strakowski et al.
2008), and none of the studies reported statistical power
to demonstrate whether their sample sizes were large
enough to illustrate meaningful differences between
groups.
Cognitive impairment in acute mania
Group differences in cognitive functioning for the acute
studies are reported in Table 3. Various components of
executive functioning were examined in the included
studies.
Cognitive flexibility Significant differences were identi-
fied between groups in perseverative errors, persevera-
tive responses, non-perseverative errors and unique
errors in the Wisconsin Card Sorting Test (WCST) with
medium effect sizes (Cohen’s d ranging from 0.43 to
0.65). No significant differences were observed in the
ability to maintain set.
Response inhibition No significant differences were
found in the number of correct target and stop signal re-
sponses, discriminability and response reaction time in
the stop signal test.
Verbal fluency FEM and HCs did not significantly differ
in the number of correct responses and perseverative er-
rors for both phonemic and semantic fluency on the
Controlled Oral Word Association Task.
Cognitive impairment in remission from FEM
Cognitive functioning mean group differences between
remission and HC participants are displayed in Table 4.
Processing speed All four studies included at least one
measure of processing speed; however, the findings were
mixed. Two studies identified significant differences be-
tween groups in completion time for the colour-naming
task of the colour-word interference test, digit symbol
coding, part A of the Trail Making Test (TMT-A) and
grooved pegboard; on the contrary, two other studies
found no significant difference between FEM and HC
participants in colour or word naming (Stroop), digit
symbol coding and TMT-A.
Attention
Attention span
Three of the four studies that assessed attention span
found that there were no significant differences between
groups in the California Verbal Learning Test (CVLT)
trial I or in digit span forward. Conversely, one study re-
ported that HCs performed significantly better than
FEM patients with respect to digit span forward.
Sustained attention
A medium to large effect (Cohen’s d with Hedges’
correction = 0.62) was noted in rapid visual information
processing, with HCs significantly surpassing the per-
formance of FEM patients.
Memory
Verbal learning and memory
All four studies compared verbal learning and mem-
ory abilities in FEM patients and HCs. One study re-
ported that patients recalled significantly less words
on CVLT trials 1 to 5 compared to HCs with
medium to large effect noted (Cohen’s d with Hedges’
correction = 0.61); though, there was no significant
difference in delayed recall. On the contrary, another
study reported no significant difference between
groups in trials 1 to 5, though patients without a pre-
vious history of untreated manic symptoms performed
significantly poorer than HCs in delayed recall, with
medium effect (η2 = 0.06).
Of the three studies that used the Wechsler Memory
Scale (WMS) to assess verbal memory, two reported no
significant difference in WMS-III subtests. However, one
study found that patients performed significantly poorer
than HCs on all subtests of the WMS-Revised besides
visual reproduction.
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Table 3 Summary of findings for the FEM acute studies
Cognitive function Controls FEM Statistics Study
Domain Test Specific n Mean (SD) n Mean (SD) p value Effect size First author (year)
Executive function Wisconsin Card Sorting Test Perseverative errors (%) 48 12.4 (10.7) 21 19.2 (12.2) 0.01a,b 0.59e Fleck et al. (2008)
Perseverative responses (n) 48 14.8 (18.9) 21 28.3 (22.6) 0.01a,b 0.65e
Non-perseverative errors (n) 48 13.1 (14.8) 21 19.5 (13.8) 0.001a,b 0.43e
Unique errors (n) 48 1.8 (5.3) 21 4.9 (8.6) 0.001a,b 0.47e
Failure to maintain set (n) 48 0.6 (0.9) 21 0.5 (1.0) 0.32a 0.13e
Stop signal design Targets, correct (%) 16 50 (12) 16 44 (20) 0.13c NR Strakowski et al. (2008)
Stops, correct (%) 16 89 (9) 16 91 (7) 0.25c NR
Discriminability 16 0.85 (0.04) 16 0.87 (0.06) 0.27c NR
Bias 16 0.14 (0.03) 16 0.11 (0.05) 0.17c NR
Target, RT (ms) 16 580 (10) 16 575 (36) 0.57c NR
Controlled Oral Word
Association Test
FAS 30 39.57 (11.07) 19 38.52 (10.95) >0.05d NR Lebowitz et al. (2001)
Animal category 30 19.71 (3.69) 19 18.43 (3.63) >0.05d NR
n, number; RT, reaction time; ms, milliseconds; NR, not reported. aKruskal-Wallis and Chi-square tests; bsignificant difference between groups after Mann-Whitney U test for pairwise comparisons; cone-sample t-tests;
done-way or univariate analysis of variance; eCohen’s d.
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Table 4 Summary of findings for the FEM remission studies
Cognitive function Controls FEM Statistics Study
Domain Test Specific n Mean (SD) n Mean (SD) p value Effect size First author (year)
Processing speed Colour-word interference (D-KEFS) Colour naming 110 28.2 (4.8) 34 31.6 (7.3) 0.002b,e 0.08g Hellvin et al. (2012)
21a 32.2 (9.2)
Word naming 110 21.5 (3.3) 34 22.1 (3.5) 0.161b 0.02g
21a 23.1 (4.4)
Grooved pegboard N/A 110 64.0 (7.7) 34 74.7 (16.0) <0.001b,e 0.20g
21a 77.4 (16.6)
Stroop Word naming 25 103.2 (13.7) 45 100.2 (12.9) >0.05c,f 0.09h Torres et al. (2010)
Colour naming 25 73.7 (12.3) 45 72.5 (11.8) >0.05c,f 0.07h
Trail Making Test A 50 83.70 (4.21) 50 94.00 (7.72) <0.001c NR Elshahawi et al. (2011)
66 55.89 (19.99) 24 52.50 (18.27) >0.05d <0.2i Lopez-Jaramillo et al. (2010)
25 20.8 (6.4) 45 26.0 (7.8) >0.05c,f 0.55h Torres et al. (2010)
WAIS/WAIS-III Digit symbol coding 50 11.02 (2.48) 50 7.36 (0.53) <0.001b NR Elshahawi et al. (2011)
66 40.92 (12.92) 24 38.63 (12.37) >0.05d <0.2i Lopez-Jaramillo et al. (2010)
110 78.1 (14.6) 34 66.8 (14.8) <0.001b,e 0.11g Hellvin et al. (2012)
21a 67.6 (14.3)
Attention CANTAB RVIP 25 0.92 (0.04) 45 0.89 (0.05) 0.008c,e,f 0.62h Torres et al. (2010)
CVLT Trial 1 25 7.0 (1.6) 45 6.5 (1.9) >0.05c,f 0.28h Torres et al. (2010)
WAIS-III/WMS/WMS-Revised Digit span forward 110 6.2 (1.1) 34 5.9 (1.2) 0.33b 0.01g Hellvin et al. (2012)
21a 6.0 (1.3)
66 5.39 (1.14) 24 5.42 (0.97) >0.05d <0.2i Lopez-Jaramillo et al. (2010)
50 6.44 (0.54) 50 4.14 (0.35) <0.001c NR Elshahawi et al. (2011)
Learning and memory CANTAB Pattern recognition 25 97.0 (3.3) 45 94.6 (7.0) >0.05c,f 0.27h Torres et al. (2010)
Spatial recognition 25 83.2 (11.8) 45 76.8 (15.2) >0.05c,f 0.40h
Paired associates 25 4.9 (5.4) 45 9.1 (6.5) >0.05c,f 0.45h
CVLT Total trials 1 to 5 110 57.2 (9.2) 34 53.8 (13.7) 0.158b 0.02g Hellvin et al. (2012)
21a 54.0 (10.6)
25 58.7 (7.7) 45 51.6 (11.6) 0.004c,e,f 0.61h Torres et al. (2010)
Delayed recall 110 13.2 (2.4) 34 11.3 (4.2) 0.007b,e 0.06g Hellvin et al. (2012)
21a 12.5 (3.0) >0.05b
25 12.7 (2.7) 45 10.9 (3.0) >0.05c,f 0.57h Torres et al. (2010)
Rey Complex Figure Delayed recall 109 22.8 (6.1) 34 20.8 (7.5) 0.030b 0.04g Hellvin et al. (2012)
21a 19.1 (6.0)
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Table 4 Summary of findings for the FEM remission studies (Continued)
Immediate recall 66 18.33 (10.98) 24 14.79 (5.09) >0.05d <0.4i Lopez-Jaramillo et al. (2010)
WMS Logical memory (LM) 66 10.05 (3.64) 24 8.92 (2.78) >0.05d <0.4i Lopez-Jaramillo et al. (2010)
Visual reproduction 66 8.70 (2.83) 24 7.71 (3.38) >0.05d <0.4i
Associated pairs 66 14.86 (3.46) 24 13.69 (4.15) >0.05d <0.4i
LM recognition 66 17.29 (3.13) 24 18.53 (2.14) >0.05d <0.6i
WMS-Revised Information 50 5.98 (0.14) 50 5.32 (0.47) <0.001c NR Elshahawi et al. (2011)
Mental control 50 5.78 (0.76) 50 4.78 (1.27) <0.001c NR
Logical memory 50 13.93 (1.72) 50 11.91 (1.19) <0.001c NR
Visual reproduction 50 10.66 (0.96) 50 10.80 (1.01) 0.479c NR
Total memory 50 74.51 (4.08) 50 62.93 (3.30) <0.001c NR
WMS-III LM, learning 110 26.5 (6.5) 34 24.9 (7.9) 0.381b 0.01g Hellvin et al. (2012)
21a 24.9 (4.5)
LM, recall 110 23.8 (7.2) 34 20.9 (8.2) 0.084b 0.03g
21a 21.4 (5.3)
Visuospatial processing Benton Judgement of line orientation 25 29.0 (2.0) 45 27.4 (3.0) >0.05c,f 0.45h Torres et al. (2010)
Executive functions CANTAB Stockings 25 10.4 (1.6) 45 9.0 (2.4) 0.002c,e,f 0.64h Torres et al. (2010)
I/E-D 25 3.1 (5.2) 45 7.8 (8.9) 0.002c,e,f 0.61h
Colour-word interference (D-KEFS) Inhibition 110 49.4 (10.5) 34 59.9 (26.6) <0.001b,e 0.09g Hellvin et al. (2012)
21a 61.1 (18.9)
Inhibition/switching 110 55.6 (12.5) 34 60.9 (25.4) 0.033b 0.04g
21a 65.1 (20.6)
Letter-number sequencing N/A 109 11.2 (2.3) 34 9.6 (3.1) <0.001b,e 0.09g
20a 9.4 (2.4)
25 12.0 (3.1) 45 10.8 (2.6) >0.05c,f 0.37h Torres et al. (2010)
Spatial working memory N/A 25 9.2 (16.7) 45 21.0 (20.1) <0.001c,e,f 0.72h Torres et al. (2010)
Stroop Conflict time 66 62.91 (13.78) 24 65.04 (11.91) >0.05d <0.2i Lopez-Jaramillo et al. (2010)
Conflict errors 66 2.02 (2.00) 24 2.25 (2.95) >0.05d <0.2i
Interference 25 49.7 (12.4) 45 47.0 (9.3) >0.05c,f 0.20h Torres et al. (2010)
Trail Making Test B 50 232.50 (23.24) 50 264.50 (40.19) <0.001c NR Elshahawi et al. (2011)
66 106.95 (55.88) 24 127.67 (90.48) >0.05d <0.4i Lopez-Jaramillo et al. (2010)
25 46.1 (12.6) 45 58.5 (23.8) >0.05c,f 0.58h Torres et al. (2010)
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Table 4 Summary of findings for the FEM remission studies (Continued)
WAIS-III Digit span backward 110 4.8 (1.2) 34 4.1 (1.1) 0.009b,e 0.06g Hellvin et al. (2012)
21a 4.3 (1.2) >0.05b
WCST Perseveration errors 50 10.52 (3.73) 50 26.14 (6.92) <0.001c NR Elshahawi et al. (2011)
Perseveration responses 72 7.1 (3.7) 34 7.8 (3.5) 0.703b <0.01g Hellvin et al. (2012)
15a 7.5 (3.3)
Category completion 50 5.84 (0.42) 50 4.40 (1.44) <0.001c NR Elshahawi et al. (2011)
72 3.7 (1.2) 34 3.8 (1.2) 0.962b <0.01g Hellvin et al. (2012)
15a 3.7 (1.3)
Total errors 72 14.4 (6.4) 26 15.4 (7.2) 0.713b <0.01g
15a 15.6 (6.2)
WCST (short version) Perseverative responses 66 16.56 (6.74) 24 19.29 (8.61) >0.05d <0.4i Lopez-Jaramillo et al. (2010)
Perseverative errors 66 25.17 (7.42) 24 26.42 (8.37) >0.05d <0.2i
Categories 66 2.79 (1.21) 24 2.67 (1.24) >0.05d <0.2i
WMS/WMS-Revised Digit span backward 66 3.08 (1.06) 24 3.83 (1.02) 0. 005d 0.73i Lopez-Jaramillo et al. (2010)
50 5.30 (0.79) 50 3.66 (0.48) <0.001c NR Elshahawi et al. (2011)
Verbal fluency (DKEFS) Letter 110 43.0 (10.1) 34 41.3 (13.3) 0.755b <0.01g Hellvin et al. (2012)
21a 42.3 (13.6)
Category 110 48.9 (8.5) 34 44.9 (11.0) 0.208b 0.02g
21a 45.8 (11.7)
Category switching 110 14.9 (2.4) 34 14.0 (2.8) 0.199b 0.02g
21a 14.5 (3.6)
Verbal fluency Semantic 66 18.08 (3.53) 24 17.60 (3.21) >0.05d <0.2i Lopez-Jaramillo et al. (2010)
Phonological 66 12.31 (3.64) 24 11.23 (2.94) >0.05d <0.4h
FAS 25 41.4 (12.6) 45 38.5 (9.7) >0.05c,f 0.23h Torres et al. (2010)
Intelligence K-BIT Vocabulary score 25 103.5 (9.6) 45 102.3 (11.3) >0.05c,f 0.09h
Matrices 25 113.4(7.7) 45 106.6(11.6) 0.01c,e,f 0.59h
WAIS Verbal IQ 50 100.58 (9.71) 50 90.22 (6.02) <0.001b NR Elshahawi et al. (2011)
Performance IQ 50 104.06 (9.83) 50 84.86 (4.80) <0.001b NR
Full scale IQ 50 100.80 (8.87) 50 86.58 (4.62) <0.001b NR
66 99.53 (14.2) 24 96.24 (14.7) 0.002b 0.10i Lopez-Jaramillo et al. (2010)
WASI Vocabulary 110 60.6 (7.3) 34 60.3 (8.8) 0.902b <0.01g Hellvin et al. (2012)
21a 61.2 (6.6)
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Table 4 Summary of findings for the FEM remission studies (Continued)
Similarities 110 38.5 (5.2) 34 37.4 (5.1) 0.555b <0.01g
21a 37.9 (4.1)
Block design 110 55.6 (10.2) 34 47.2 (15.9) <0.001b,e 0.11g
21a 46.0 (12.2)
Matrix reasoning 110 28.2 (3.3) 34 27.8 (5.8) 0.042b 0.04g
21a 25.7 (4.8)
Full scale IQ 110 111.6 (11.4) 34 108.6 (14.7) 0.159b 0.02g
21a 106.9 (9.6)
FEM, first-episode mania; D-KEFS, Delis-Kaplan Executive System; WAIS, Wechsler Adult Intelligence Scale; CANTAB, Cambridge Neuropsychological Test Automated Battery; CVLT, California Verbal Learning Test; WMS,
Wechsler Memory Scale; K-BIT, Kaufman Brief Intelligence Test; WASI, Wechsler Abbreviated Scale of Intelligence; RVIP, Rapid Information Visual Processing; I/E-D, intra/extra-dimensional test; NR, not reported. aFEM
participants with previously untreated manic symptoms; bone-way ANOVA or univariate ANOVA; ctwo-tailed, independent-samples t-test, univariate t-test or student t-test; dMann-Whitney U test; esignificant difference
after Bonferroni correction, ANOVA and t-test; fz-scores used in main analysis and effect size; geta squared; hCohen’s d with Hedges’correction; ieffect size (ES) calculation for Mann-Whitney U, ES> 0.70 was
considered significant.
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Non-verbal learning and memory
There were no significant differences between groups
in spatial learning and memory as assessed by the Rey-
Osterrieth Complex Figure Test in immediate and de-
layed recall and in the Cambridge Neuropsychological
Test Automated Battery for pattern and spatial recogni-
tion and paired associates.
Visuospatial orientation There was no significant dif-
ference between groups for Benton’s Judgment of Line
Orientation.
Executive function
Cognitive flexibility
Of the three studies that measured cognitive flexibility,
only one study reported a highly significant difference in
WCST and in the time to complete TMT-B, with
patients performing substantially worse than the HCs.
Response inhibition
Patients performed poorer than HCs in response inhib-
ition as measured by the completion time of the colour-
word interference test (η2 = 0.09). No significant difference
was found between FEM and HC participants in conflict
mistakes and conflict time of the Stroop interference test.
Set shifting
Patients performed significantly poorer than HCs in
the attentional set shifting intra/extra-dimensional task
with medium to large effect noted (Cohen’s d with
Hedges’correction = 0.61).
Spatial planning
Patients had significantly poorer performance on the
stockings of Cambridge than HCs with medium to large
effect noted (Cohen’s d with Hedges’correction = 0.64).
Verbal fluency
There were no significant differences between patients
and HCs on both semantic and phonological verbal flu-
ency tasks.
Working memory (verbal and non-verbal)
FEM patients had poorer verbal working memory com-
pared to HCs on the digit span backward task, with
medium effect (η2 = 0.06) for FEM patients without a pre-
vious history of untreated manic symptoms. One study
found a highly significant difference in letter-number se-
quencing with medium to large effect for all FEM patients
(η2 = 0.09), whereas another study reported no significant
difference between groups on this measure.
Spatial working memory scores were significantly poorer
for the remission group compared to those for the HCs
with medium to large effect (Cohen’s d with Hedges’
correction = 0.72).
Intelligence Four studies compared the current IQ of
FEM patients and HCs. One study found that there was
no significant difference in verbal IQ as measured by the
Kaufman Brief Intelligence Test; however, spatial reason-
ing (matrices) was significantly poorer for patients in re-
mission than that for HCs with medium effect (Cohen’s d
with Hedges’correction = 0.59). Similarly, another study
found that FEM patients and HCs performed alike on all
Wechsler Abbreviated Scale of Intelligence subscales, be-
sides block design in which HCs performed superior to
patients with medium to large effect (η2 = 0.11).
On the contrary, one study reported that the FEM group
performed significantly poorer on all subscales of the
Wechsler Adult Intelligence Scale except for the arith-
metic subtest.
Confounding variables
Clinical characteristics There was no significant correl-
ation between the following clinical variables and cognitive
functioning: illness duration, age of illness onset, age of
manic episode onset, treatment delay, time elapsed from
FEM, previous depressive episode, prior hypomanic epi-
sode, mood or psychotic symptoms or substance abuse co-
morbidity. A potential confounding variable for cognitive
flexibility in acute mania was premorbid intelligence, with
a significant relationship identified for all WCST measures
besides failure to maintain set.
Psychiatric treatment/medication Treatment medica-
tion posed a potential confounding variable for remission
patients. One study found that patients in remission taking
lithium (n= 16) performed significantly better in spatial
reasoning/orientation and executive functioning tasks than
patients on divalproex (n= 20). No significant correlation
was identified in the dose of either lithium or divalproex on
cognitive performance. Patients on lithium treatment per-
formed poorer on memory tasks compared to HCs, whilst
patients treated with divalproex performed significantly
poorer than HCs in executive functions, spatial reasoning
and memory tasks. Patients treated with an atypical anti-
psychotic (n= 30) and those without (n= 15) did not differ
regarding frequency of treatment and performed similarly
across all cognitive domains. Whilst another study found
that there were no significant differences between medi-
cated and unmedicated FEM patients in reaction time, dis-
criminability and bias for the response inhibition task, one
study reported that increased daily dosage of antipsychotic
medication was significantly correlated with a slower per-
formance on grooved pegboard (p= 0.01).
Discussion
This systematic review and quality assessment examined
cognitive functioning in FEM. Based on our stringent in-
clusion and exclusion criteria, studies on cognitive func-
tioning in the acute and remission phases of FEM were
limited to three and four studies, respectively. All studies
had limitations indexed by omitting at least three quality
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indicators based on the Newcastle-Ottawa scale. The cog-
nitive assessment during the acute phase was restricted to
the executive functioning domain, with the findings of im-
pairment in cognitive flexibility but not in response inhib-
ition and verbal fluency. Collectively, the findings were
largely mixed, although individual studies during the remis-
sion phase revealed deficits in several cognitive domains.
The most consistent cognitive deficit during remission was
in working memory, whilst the impairments identified in
sustained attention, set shifting and spatial planning were
only found in one study. Another consistent finding was
that verbal fluency and non-verbal memory were not im-
pacted during remission from FEM. Due to the limited
number of studies in FEM and the inconsistency of the
findings during the remission phase, the widespread cogni-
tive deficits as reported by a recent meta-analysis in first-
episode bipolar disorder could not be confirmed by this
review (Lee et al. 2014).
First acute mania and cognition
The first stage of this systematic review was to examine the
impact of a first acute manic state on cognitive functioning.
Acute patients with comorbid psychiatric disorders, includ-
ing substance abuse within 3 months of neuropsychological
testing, were excluded from the studies. Although acute
and HC participants were closely matched on several
demographic variables, acute patients were less educated
than HCs in one study (Lebowitz et al. 2001), and no com-
parison was made between groups on premorbid IQ in an-
other study (Strakowski et al. 2008). Furthermore, caution
needs to be taken in the interpretation of the results due to
the potential biases posed by the extant literature. Also, the
severity of symptoms of the FEM patients varied substan-
tially, with some patients presenting as floridly unwell,
whilst others were under-threshold for an acute episode at
the time of testing.
In this review, acute FEM patients substantially
differed from HCs on all but one measure (failure to
maintain set) of the cognitive flexibility task (WCST).
The non-significant difference was likely attributed to a
‘flooring effect’due to the low distribution of scores
across both groups, though premorbid IQ may have had
a confounding effect. Acutely manic patients and HC
participants showed similar levels of impulsivity in the
stop signal task. After controlling for premorbid IQ, a
study by Martinez-Aran et al. (2004) revealed that indi-
viduals with chronic bipolar disorder performed worse
in cognitive flexibility (WCST) and response inhibition
(Stroop) during acute states of illness (mania/hypomania
and depression) and in the euthymic phase when com-
pared to HCs. However, the low inter-correlation be-
tween the stop signal and Stroop tasks indicates that the
tests may be sensitive to different functions of response
inhibition (Khng and Lee 2014). These findings suggest
that prefrontal dysfunction associated with cognitive in-
flexibility, but not response inhibition, may be a trait fac-
tor of bipolar disorder that arises from the first acute
episode (Soares 2003; Lyoo et al. 2004; Morice 1990).
Interestingly, even though hyperverbosity is a common
feature of acute mania, a similar level of phonemic and se-
mantic verbal fluency was reported between acute patients
and HCs. The number of error intrusions and persevera-
tive responses remained consistent between groups sug-
gesting that FEM does not significantly impact fluency
output. However, the same study revealed that acutely
manic patients with multiple episodes had a significant re-
duction in verbal fluency relative to HCs, even when er-
rors were included in the total number of responses.
Martinez-Aran et al. (2004) identified that only depressed
bipolar patients were impaired in phonemic fluency and
that both depressed and euthymic patients, although not
manic patients produced less semantic words than HCs.
Remission from FEM and cognition
In the second part of this systematic review, the extent of
cognitive dysfunction in the period following acute FEM
was examined. Although individual studies revealed im-
pairments across all cognitive domains, the between study
findings were inconsistent for most cognitive tasks besides
working memory. For example, the impairments identified
in processing speed, attention span, sustained attention,
verbal immediate memory, delayed verbal memory, verbal
intelligence and non-verbal intelligence were contradicted
by null findings or were reported by only one study.
Whilst one study found no deficit in visuospatial orienta-
tion, several studies suggested that non-verbal memory
was not impacted in remission from FEM.
Regarding executive functioning, FEM patients with-
out prior treated manic symptoms presented with a
poorer working memory capacity and spatial working
memory than HCs. FEM and HC participants per-
formed similarly in response inhibition when residual
symptoms were controlled, though deficits in response
inhibition were identified by one study of FEM patients
with ongoing symptomatology (Hellvin et al. 2012).
Most studies found that there was no difference in cog-
nitive flexibility during remission from FEM compared
to HCs, besides one study of FEM patients with previ-
ous psychotic features (Elshahawi et al. 2011). Consist-
ent with the findings in the acute phase, all studies that
measured verbal fluency during remission identified
that FEM patients and HCs performed similarly in both
semantic and phonological categories.
In comparison, a recent meta-analysis of 12 studies on
cognition in first-episode bipolar disorder in adults by
Lee et al. (2014) found deficits of medium to large effect
for processing speed, cognitive flexibility and attention
and working memory, with smaller effects identified for
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deficits in verbal learning and memory and ability to main-
tain set and verbal fluency. Overall, there was an overlap of
five out of the seven studies in the current review from the
meta-analysis. It appears that the only two studies that iden-
tified impairments in processing speed and cognitive flexibil-
ity in the meta-analysis but did not met eligibility criteria for
inclusion in the current review had included participants
from a broader spectrum of bipolar disorders (i.e. bipolar I
and II) and were not well matched to the control group in
age, gender (Nehra et al. 2006), education and/or estimated
verbal intelligence (Gruber et al. 2008; Nehra et al. 2006).
Similarly, the meta-analysis reported no impairment ob-
served in visual learning and memory relative to HCs, and
response inhibition was only observed in symptomatic pa-
tients (Lee et al. 2014). Although our findings identified that
response inhibition was not impaired during the first acute
manic episode in a sample of young people with bipolar dis-
order (between 15 and 35 years of age) (Strakowski et al.
2008), a deficit was observed in patients who had mainly re-
covered from mania but were mildly depressed at the time
of testing (Hellvin et al. 2012). Interestingly, residual depres-
sive symptoms, though not residual manic symptoms, were
found to have a confounding effect on cognitive functions
such as processing speed and cognitive flexibility in a meta-
analysis on euthymic bipolar disorder in adults (Bourne
et al. 2013).
In support of the findings on cognitive inflexibility by
Elshahawi et al. (2011), a meta-analysis on bipolar I disorder
by Bora et al. (2007) found that euthymic patients with pre-
vious psychotic symptoms had poorer cognitive flexibility
(as measured by categories on the WCST) than euthymic
patients without prior psychotic symptoms and HCs, even
after controlling for confounding variables such as educa-
tion, age, residual symptoms and illness severity. Fleck et al.
(2008) identified that euthymic patients with bipolar dis-
order performed worse than HCs in the same cognitive
flexibility task, although they performed better than multi-
episode and first-episode acutely manic patients. Moreover,
multiple-episode patients had poorer cognitive flexibility
than FEM patients and HCs. Therefore, cognitive flexibility
is likely to be associated with psychotic features, mood state
and disease course.
Given that variations in illness severity may impact cog-
nitive findings, there is a possibility that this was a contrib-
uting factor to the large differences between the overall
study findings in this review. For example, one study re-
ported that patients with past psychotic features, repre-
senting the more severe end of the bipolar disorder
spectrum, performed significantly worse than HCs on all
cognitive tests, including processing speed, memory, ex-
ecutive functions and intelligence (Elshahawi et al. 2011).
Another study that did not report the presence of past
psychotic symptoms found that the only significant differ-
ence in FEM compared to HCs was in working memory
(Lopez-Jaramillo et al. 2010). A meta-analysis by Bora
et al. (2010) found that patients with bipolar disorder with
a history of psychosis performed poorer in processing
speed, verbal memory, planning and reasoning and work-
ing memory than patients without a prior psychotic his-
tory. Another factor that may have contributed to these
inconsistencies pertains to the quality of the study design.
With regard to selection criteria, Lopez-Jaramillo et al.
(2010) recruited healthy relatives of FEM participants as
the control group, which may have influenced the find-
ings. Past research has shown that unaffected relatives of
patients with bipolar disorder may have deficits in specific
cognitive tasks compared to HCs (Bora et al. 2009; Ferrier
et al. 2004; Robinson and Ferrier 2006; Arts et al. 2008).
The findings of cognitive deficits in relatives of patients
with bipolar disorder are suggestive of pre-existing devel-
opmental or genetic vulnerability (Ferrier et al. 2004; Zalla
et al. 2004). Thus, relatives are not optimal as control par-
ticipants as they may have reduced the capacity to detect
the extent of cognitive deficits present in the FEM group.
FEM patients and HCs were matched on several demo-
graphic variables. Hence, these variables were not likely to
have influenced the cognitive findings; although, Hellvin
et al. (2012) had group matched FEM patients and HCs at a
ratio of 2:1. Furthermore, clinical factors such as age of on-
set and illness duration were not associated with poorer cog-
nitive performance in FEM (Hellvin et al. 2012; Torres et al.
2010). This is contrary to previous reports of worse cogni-
tive functioning associated with earlier age of onset, in-
creased number of affective episodes, hospitalisations and
duration of illness in people with bipolar disorder (Ali et al.
2001; Denicoff et al. 1999; Glahn et al. 2004; Savitz et al.
2009; Tham et al. 1997; van Gorp et al. 1998). However, dif-
ferences in patients’treatment medication were found to
have an effect on cognitive functioning in FEM. Patients
treated with lithium outperformed patients on divalproex on
several cognitive tasks (Torres et al. 2010), whilst an increase
in the daily dose of antipsychotic medication trended to-
wards poorer processing speed in FEM patients (Hellvin
et al. 2012). A study by Kravariti et al. (2005) found that a
higher dose of lithium was associated with fewer errors on
an executive functioning task in people with bipolar
disorder, though there was no relationship between the dose
of antipsychotic medication and task performance.
Strakowski et al. (2008) reported no difference in response
inhibition between medicated and unmedicated patients;
however, the sample size was small, the treatment was not
specified and the patients had only received medication for
a few days prior to the cognitive assessment.
Cognition in FEM compared with multi-episode bipolar
disorder
The findings from this review relative to meta-analyses on
multi-episode bipolar disorder suggest that there may be a
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worsening of cognition with progression of illness (Bora
et al. 2009; Mann-Wrobel et al. 2011; Arts et al. 2008;
Bourne et al. 2013; Robinson et al. 2006). When comparing
their findings on FEM to previously published studies on
multiple-episode patients, Torres et al. (2010) reported that
although premorbid/verbal IQ, attention and processing
speed were similar with FEM patients, the multiple-episode
patients performed worse in measures of executive func-
tioning and verbal memory. Similarly, Hellvin et al. (2012)
found that FEM and multiple-episode patients performed
alike in measures of verbal recall and executive functioning,
though multiple-episode patients were more impaired in
verbal memory, attention and verbal fluency. Two studies
in this review assessed the effects of multiple episodes on
cognitive functioning in addition to FEM (Elshahawi et al.
2011; Lopez-Jaramillo et al. 2010). Their findings revealed
that those with recurrent episodes performed worse in
attention, processing speed and executive functions (Lopez-
Jaramillo et al. 2010; Elshahawi et al. 2011) even after
accounting for covariates, such as disease onset, chronicity,
depression and medication (Lopez-Jaramillo et al. 2010).
Moreover, a recent longitudinal study on FEM patients re-
vealed an improvement in processing speed and executive
functions relative to HCs over a 1-year period after the first
acute manic episode (Torres et al. 2014). However, patients
who relapsed during the 1-year follow-up period did not
show improvement in cognitive functioning and those who
had a longer duration of relapse for mania and hypomania
showed further cognitive decline (Kozicky et al. 2014). Al-
though there appears to be an improvement in cognitive
functioning in FEM patients who have remained well, there
has only been one longitudinal study on cognitive function-
ing in FEM. Therefore, further longitudinal studies examin-
ing cognitive functioning in FEM patients is warranted,
particularly in relation to the effects of long-term medica-
tion use as well as illness course, such as relapses.
Limitations
Only seven studies were located by the search according
to the eligibility criteria. Whist well-formulated inclu-
sion and exclusion criteria strengthen the aims and
overall findings, they also limit the ability to confer as-
sociations between studies on cognitive functioning in
juvenile bipolar disorder, first-episode affective disor-
ders and in first-episode bipolar disorders when episode
polarity was not specified. Another limitation relates to
the cross-sectional nature of the studies, meaning that
there was no assessment of cognitive functioning prior
to the onset of the illness. It is unclear from this review
whether the cognitive deficits in the early stages of bipo-
lar disorder had commenced after illness onset or were
present during the prodromal or premorbid phase. Add-
itionally, due to the shared variance between cognitive
functions such as attention and processing speed (Antila
et al. 2011), there can be a loss of specificity in relation
to the exact area of cognition impacted.
Conclusions
This systematic review has revealed a relatively robust
deficit in working memory, with evidence of impairment
in several other cognitive domains in some, but not all
studies included in this review. There was no evidence of
dysfunction in verbal fluency during both the acute state
and remission period of a FEM, and non-verbal memory
does not appear impacted during remission. This suggests
a finite window for potentially neuroprotective effects as
past literature on chronic bipolar disorder has identified
deficits in both these domains, highlighting the theoretical
importance of early intervention and treatment adherence.
Longitudinal research on cognitive functioning after the
onset of bipolar I disorder is needed in order to assess the
extent to which cognitive deficits progress over time.
Addit ional file
Addit ional file 1: Table S1. Cognitive domains and functions
represented by the neuropsychological test utilised in the studies.
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